(Q40596772)

21 September 2017

title

Dissolved urate salts out calcium oxalate in undiluted human urine in vitro: implications for calcium oxalate stone genesis (English)

1 reference

21 September 2017

1 reference

Phulwinder K Grover

1

1 reference

21 September 2017

Villis R Marshall

series ordinal

2

1 reference

21 September 2017

Rosemary L Ryall

series ordinal

3

1 reference

21 September 2017

publication date

1 March 2003

1 reference

21 September 2017

published in

Chemistry and Biology

1 reference

21 September 2017

volume

10

1 reference

21 September 2017

issue

3

1 reference

21 September 2017

page(s)

271-278

1 reference

Uric acid nephrolithiasis in gout. Predisposing factors

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

Uricemia and Urolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

Presence or absence of inhibitor of calcium-oxalate crystal growth in urine of normals and of stoneformers

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

Allopurinol treatment of uric-acid disorders in calcium-stone formers

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

Hypercalciuria and Hyperuricosuria in Patients with Calcium Nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

Allopurinol and Urolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

Effect of oral purine load and allopurinol on the crystallization of calcium salts in urine of patients with hyperuricosuric calcium urolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

Allopurinol in the prevention of calcium oxalate renal stones. Preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

Prevention of calcium nephrolithiasis with low-dose thiazide, amiloride and allopurinol

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

Randomized trial of allopurinol in the prevention of calcium oxalate calculi.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

Sodium Urate Accelerates Precipitation of Calcium Oxalate In Vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

Heterogeneous Nucleation of Calcium Oxalate by Seeds of Monosodium Urate

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

Influence of the salting-out effect on the formation of calcium oxalate crystals in human urine

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

A simple salting out procedure for extracting DNA from human nucleated cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

Salting-out procedure for isolation of DNA from stored bone marrow slides for PCR

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

Salting‐out of enzymes with ammonium sulphate

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

A new salting-out technique for colorimetric free fatty acid assays

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

Effect of urate on calcium oxalate crystallization in human urine: evidence for a promotory role of hyperuricosuria in urolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

Calcium oxalate crystallization in urine: role of urate and glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

Dissolved urate promotes calcium oxalate crystallization: epitaxy is not the cause

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

A method for studying inhibitory activity in whole urine

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

Urate and calcium stones--picking up a drop of mercury with one's fingers?

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

Urate does not influence the formation of calcium oxalate crystals in whole human urine at pH 5.3.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

Effects of chondroitin sulphate, human serum albumin and Tamm-Horsfall mucoprotein on calcium oxalate crystallization in undiluted human urine

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

Fluorescence assay for picomole quantities of ammonia

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

The estimation of pyrophosphate in urine with uridine-5′-diphosphoglucose pyrophosphorylase

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900057-7

7 January 2021

10.1016/S1074-5521(03)00057-7

Identifiers

DOI

1 reference

21 September 2017

1 reference